CGGRGD TFA (1260223-44-6 free base)

Research use only, not for human use.

CGGRGD TFA is synthesized via solid-phase peptide synthesis technique and the surface of PCL fibers is aminolysised by amino 2-cyanobenzothiazole followed by the addition of 2-cyanobenzothiazole (CBT).

CGGRGD TFA is synthesized via solid-phase peptide synthesis technique and the surface of PCL fibers is aminolysised by amino 2-cyanobenzothiazole followed by the addition of 2-cyanobenzothiazole (CBT).(In Vitro):CGGRGD TFA is a characteristic sequence of fifibronectin that binds to the receptors on cell surface. (PCL) is a popular materials for tissue engineering due to its optimal biocompatibility, biodegradability, and thermoplastic characteristics.

Others

Other Targets

——

——

——

--

677.6

C21H34F3N9O11S

>98% (HPLC)

——

——

(-20℃)

With Ice Pack

≥ 2 years